Funding submissions for a novel bio-engineered product.

Context: The medical supplier wanted hospitals to allocate funds to cover the purchase of a set number of courses of treatment with a novel bio-engineered product.  The product formed part of a revolutionary new therapy.
Actions: Comprehensive funding submissions were prepared for individual hospitals, incorporating case studies of their local experience of the product as well as a national retrospective/prospective cost analysis of therapy patients. 

We partnered with key stakeholders within each hospital to identify potential funding pathways and lobby appropriate funding gatekeepers.
Outcome: Funding was obtained at the individual hospital level in many cases.  In other cases, the stakeholder took the funding submission to State government level to successfully access funding pools such as New Technology Grants.

Disclaimer | Copyright Statement